In March 2025, the company announced new strategies for your immediate-to-buyer offering of its Wegovy weight loss drug. The company set up a whole new pharmacy, called NovoCare, which might cost prospects $499 monthly for entry to the drug, less than 50 % the expense of the drug via other pharmaceutical distribution networks.[53]Difficulties with